The University of Texas Health Science Center, Houston
The purpose of this study is to see if the addition of IV Ketorolac to usual care multi-modal pain therapy compared to usual care will improve oral intake post-operatively
Inclusion Criteria: -Patient with Cleft palate (Complete and incomplete), with or without cleft lip, unilateral or bilateral Exclusion Criteria: * Syndromic Cleft Palate patients * Previous palatoplasty * Major unrepaired cardiac malformation * History of GI complications (GI Bleed, Gastric Ulceration) * History of Renal disorder * History of coagulopathy (As contraindication to NSAID use) * Feeding tube dependency * Patients whose parents refuse to consent to randomization
Ketorolac 0.5mg/kg will be administered intra-operatively at the conclusion of the case and 3 more doses scheduled every 8 hours in the first 24 hours post-operatively for a total of 4 doses of Ketorolac
0.9% Normal Saline will be administered intra-operatively at the conclusion of the case and 3 more doses scheduled every 8 hours in the first 24 hours post-operatively for a total of 4 doses of normal saline.
Arctuva estimate
Verify or correct the compensation shown for this listing.